Related references
Note: Only part of the references are listed.Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study
A. M. Weinstein et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2014)
Predictors of Marijuana Relapse in the Human Laboratory: Robust Impact of Tobacco Cigarette Smoking Status
Margaret Haney et al.
BIOLOGICAL PSYCHIATRY (2013)
Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
William W. Stoops et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Cannabis use during a voluntary quit attempt: An analysis from ecological momentary assessment
Julia D. Buckner et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users
Ryan Vandrey et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence
Magdalena Cerda et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats
Alexa A. Wakley et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
Frances R. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
Evgeny Krupitsky et al.
LANCET (2011)
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers
Ziva D. Cooper et al.
PSYCHOPHARMACOLOGY (2010)
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
Gillinder Bedi et al.
PSYCHOPHARMACOLOGY (2010)
Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls
Margaret Haney
ADDICTION BIOLOGY (2009)
Naltrexone for the treatment of obesity: review and update
Michael William Lee et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor
Ziva D. Cooper et al.
ADDICTION BIOLOGY (2008)
Advances in the field of cannabinoid-opioid cross-talk
Patricia Robledo et al.
ADDICTION BIOLOGY (2008)
Naltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
Nitya Jayaram-Lindstrom et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The role of human drug self-administration procedures in the development of medications
S. D. Comer et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Naltrexone for the management of alcohol dependence
Raymond F. Anton
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Controversies in translational research: drug self-administration
Margaret Haney et al.
PSYCHOPHARMACOLOGY (2008)
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
Marilyn A. Huestis et al.
PSYCHOPHARMACOLOGY (2007)
Abstinence rates following behavioral treatments for marijuana dependence
Ronald M. Kadden et al.
ADDICTIVE BEHAVIORS (2007)
Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers
Margaret Haney
NEUROPSYCHOPHARMACOLOGY (2007)
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Alan J. Budney et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
μ opioid and CB1 cannabinoid receptor interactions:: reciprocal inhibition of receptor signaling and neuritogenesis
Carl Rios et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Abstinence and moderate use goals in the treatment of marijuana dependence
Brian E. Lozano et al.
ADDICTION (2006)
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial
RF Anton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence
Alan J. Budney et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2006)
Injectable, sustained-release naltrexone for the treatment of opioid dependence - A randomized, placebo-controlled trial
SD Comer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Reinforcing effects of oral Δ9-THC in male marijuana smokers in a laboratory choice procedure
CL Hart et al.
PSYCHOPHARMACOLOGY (2005)
Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats
M Solinas et al.
PSYCHOPHARMACOLOGY (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Marijuana withdrawal in humans: Effects of oral THC or divalproex
M Haney et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Brief treatments for cannabis dependence: Findings from a randomized multisite trial
TF Babor et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2004)
Interaction between naltrexone and oral THC in heavy marijuana smokers
M Haney et al.
PSYCHOPHARMACOLOGY (2003)
A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone
BJ Mason et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis
SS O'Malley et al.
PSYCHOPHARMACOLOGY (2002)
Adverse effects of oral naltrexone: analysis of data from two clinical trials
C Oncken et al.
PSYCHOPHARMACOLOGY (2001)
Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
MA Huestis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Conditioned place preference induced by the cannabinoid agonist CP 55,940: Interaction with the opioid system
D Braida et al.
NEUROSCIENCE (2001)
Naltrexone does not block the subjective effects of oral Δ9-tetrahydrocannabinol in humans
SR Wachtel et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans
MK Greenwald et al.
DRUG AND ALCOHOL DEPENDENCE (2000)
Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients
HM Pettinati et al.
JOURNAL OF ADDICTIVE DISEASES (2000)